Sebela Women's Health Announces Positive Phase 3 Data for its Investigational, Next-Generation, Hormone-Free, Low-Dose Copper Intrauterine Device (IUD)

/PRNewswire/ -- Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, today announced positive results of a Phase 3 study demonstrating that...

Related Keywords

Dublin ,Ireland ,United States ,Kelly Culwell ,Davidk Turok ,Sebela Women Health Inc ,American College Of Obstetrics ,Us Food Drug Administration ,Prnewswire Sebela Women Health Inc ,Sebela Pharmaceuticals ,Department Of Obstetrics ,Sebela Pharmaceuticals Inc ,Committee Statement ,Sebela Women Health ,Drug Administration Staff ,University Of Utah ,Braintree Laboratories Inc ,Head Of Research ,Drug Administration ,Health Inc ,Pearl Index ,Sebela Women ,Principal Investigator David ,Associate Professor ,Scientific Meeting ,American College ,Private Securities Litigation Reform Act ,Technical Considerations ,Non Clinical Assessment ,Medical Devices Containing Nitinol Guidance ,Clinical Practice Bulletin ,Englj Med ,